Five Prime Therapeutics Stock Beta
Five Prime Therapeutics fundamentals help investors to digest information that contributes to Five Prime's financial success or failures. It also enables traders to predict the movement of Five Stock. The fundamental analysis module provides a way to measure Five Prime's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Five Prime stock.
Five |
Five Prime Therapeutics Company Beta Analysis
Five Prime's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Five Prime Beta | 4.63 |
Most of Five Prime's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Five Prime Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Five Prime Therapeutics has a Beta of 4.63. This is much higher than that of the Healthcare sector and 233.09% higher than that of the Biotechnology industry. The beta for all United States stocks is notably lower than that of the firm.
Five Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Five Prime's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Five Prime could also be used in its relative valuation, which is a method of valuing Five Prime by comparing valuation metrics of similar companies.Five Prime is currently under evaluation in beta category among related companies.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Five Prime will likely underperform.
Five Fundamentals
| Return On Equity | -40.58 | |||
| Return On Asset | -17.19 | |||
| Operating Margin | (579.95) % | |||
| Current Valuation | 1.5 B | |||
| Shares Outstanding | 46.57 M | |||
| Shares Owned By Insiders | 2.89 % | |||
| Shares Owned By Institutions | 97.11 % | |||
| Number Of Shares Shorted | 2.97 M | |||
| Price To Earning | (10.79) X | |||
| Price To Book | 6.57 X | |||
| Price To Sales | 134.29 X | |||
| Revenue | 13.18 M | |||
| Gross Profit | (43.24 M) | |||
| EBITDA | (73.23 M) | |||
| Net Income | (84.33 M) | |||
| Cash And Equivalents | 287.26 M | |||
| Cash Per Share | 6.27 X | |||
| Total Debt | 47.43 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 13.18 X | |||
| Book Value Per Share | 5.78 X | |||
| Cash Flow From Operations | (64.65 M) | |||
| Short Ratio | 0.76 X | |||
| Earnings Per Share | (2.29) X | |||
| Price To Earnings To Growth | 0.31 X | |||
| Number Of Employees | 51 | |||
| Beta | 4.63 | |||
| Market Capitalization | 1.77 B | |||
| Total Asset | 548.28 M | |||
| Retained Earnings | (443.25 M) | |||
| Working Capital | 448.91 M | |||
| Current Asset | 528.28 M | |||
| Current Liabilities | 79.37 M | |||
| Z Score | 22.2 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Five Prime in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Five Prime's short interest history, or implied volatility extrapolated from Five Prime options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Five Stock
If you are still planning to invest in Five Prime Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Five Prime's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges |